Flixotide 125mcg Inhaler





Flixotide 125 micrograms Evohaler is a pressurised inhalation suspension delivering 125 micrograms of fluticasone propionate per actuation. Therapeutic indications: Fluticasone propionate given by inhalation offers prophylactic treatment for asthma. Adults: Mild asthma: Patients requiring intermittent symptomatic bronchodilator asthma medication on a regular daily basis. Moderate asthma: Patients with unstable or worsening asthma despite prophylactic therapy or bronchodilator alone. Severe asthma: Patients with severe chronic asthma and those who are dependent on systemic corticosteroids for adequate control of symptoms. On introduction of inhaled fluticasone propionate many of these patients may be able to reduce significantly or to eliminate their requirement for oral corticosteroids. Children: Any child who requires prophylactic medication including patients not controlled on currently available prophylactic medication.


There are no reviews yet.

Be the first to review “Flixotide 125mcg Inhaler”

Your email address will not be published. Required fields are marked *

Shopping Cart